Clinical implications of telomerase activity levels in acute leukemia

Clinical Cancer Research

Volumn 3, Issue 4, 1997, Pages 619-625

  Ohyashiki, Junko H ^a   Ohyashiki, Kazuma ^a   Iwama, Hiroshi ^a   Hayashi, Shigefumi ^a   Toyama, Keisuke ^a   Shay, Jerry W ^b  

^a TOKYO MEDICAL UNIVERSITY   (Japan)

^b UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

TELOMERASE;

ACUTE LEUKEMIA; ADOLESCENT; ADULT; AGED; ARTICLE; CHILD; CONTROLLED STUDY; ENZYME ACTIVITY; HUMAN; HUMAN CELL; MAJOR CLINICAL STUDY; PRIORITY JOURNAL;

ADOLESCENT; ADULT; AGED; AUTOMATION; BONE MARROW; CHILD; CHILD, PRESCHOOL; CHROMOSOME ABERRATIONS; FEMALE; HUMANS; INFANT; KARYOTYPING; LEUKEMIA, LYMPHOCYTIC, ACUTE; LEUKEMIA, MYELOCYTIC, ACUTE; LEUKEMIA, MYELOID, ACUTE; MALE; MIDDLE AGED; POLYMERASE CHAIN REACTION; PRECURSOR CELL LYMPHOBLASTIC LEUKEMIA-LYMPHOMA; REFERENCE VALUES; REPETITIVE SEQUENCES, NUCLEIC ACID; TELOMERASE; TRANSLOCATION, GENETIC; TUMOR MARKERS, BIOLOGICAL;

EID: 0030964322     PISSN: 10780432     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (30)

1. Moyzis, R. K., Buckingham, J. M., Cram, L. S., Dani, M., Deaven, L. L., Jones, M. D., Meyne, J., Ratliff, R. L., and Wu, J. R. A highly conserved repetitive DNA sequence, (TTAGGG)n, present at the telomeres of human chromosomes. Proc. Natl. Acad. Sci. USA, 85: 6622-6626, 1988.
2. Harley, C. B., Futcher, A. B., and Greider, C. W. Telomeres shorten during aging of human fibroblasts. Nature (Lond.), 345: 458-460, 1990.
3. Allsopp, R. C., Vaziri, H., Patterson, C., Goldstein, S., Younglai, E. V., Futcher, A. B., Greider, C. W., and Harley, C. B. Telomere length predicts replicative capacity of human fibroblasts. Proc. Natl. Acad. Sci. USA, 89: 10114-10118, 1992.
4. Shay, J. W., Wright, W. E., and Werbin, H. Defining the molecular mechanisms of human cell immortalization. Biochem. Biophys. Acta, 1072: 1-7, 1991.
5. Harley, C. B. Telomere loss: mitotic clock or genetic time bomb? Mutat. Res., 256: 271-282, 1991.
6. Vaziri, H., Dragowska, W., Allsopp, R. C., Thomas, T. E., Harley, C. B., and Lansdorp, P. M. Evidence for a mitotic clock in human hematopoietic stem cells: loss of telomeric DNA with age. Proc. Natl. Acad. Sci. USA, 91: 9857-9860, 1994.
7. Hastie, N. D., Dempster, M., Dunlop, M. G., Thompson, A. M., Green, D. K., and Allshire, R. C. Telomere reduction in human colorectal carcinoma and with aging. Nature (Lond.), 346: 866-868, 1990.
8. Shay, J. W. Aging and cancer: are telomeres and telomerase the connection? Mol. Med. Today, 1: 378-384, 1995.
9. Shay, J. W., and Wright, W. E. Telomerase activity in human cancer. Curr. Opin. Oncol., 8: 66-71, 1996.
10. Bacchetti, S., and Counter, C. M. Telomeres and telomerase in human cancer (review). Int. J. Oncol., 7: 423-432, 1995.
11. Hiyama, K., Mirai, Y., Koizumi, S., Akiyama, M., Hiyama, E., Piatyszek, M. A., Shay, J. W., Ishioka, S., and Yamakido, M. Activation of telomerase in human lymphocytes and hematopoietic progenitor cells. J. Immunol., 155: 3711-3715, 1995.
12. Ohyashiki, K., Ohyashiki, J. H., Iwama, H., Hayashi, S., Shay, J. W., and Toyama, K. Telomerase activity and cytogenetic changes in chronic myeloid leukemia with disease progression. Leukemia (Baltimore), 11: 190-197, 1997.
13. Counter, C. M., Gupta, J., Harley, C. B., Leber, B., and Bacchetti, S. Telomerase activity in normal leukocytes and in hematologic malignancies. Blood, 85: 2315-2320, 1995.
14. Broccoli, D., Young, J. W., and de Lange, T. Telomerase activity in normal and malignant hematopoietic cells. Proc. Natl. Acad. Sci. USA, 92: 9082-9086, 1995.
15. Kim, N. W., Piatyszek, M. A., Prowse, K. R., Harley, C. B., West, M. D., Ho, P. L. C., Coviello, G. M., Wright, W. E., Weinrich, S. L., and Shay, J. W. Specific association of human telomerase activity with immortal cells and cancer. Science (Washington DC), 266: 2011-2015, 1994.
16. Piatyszek, M. A., Kim, N. W., Weinrich, S. L., Hiyama, K., Hiyama, E., Wright, W. E., and Shay, J. W. Detection of telomerase activity in human cells and tumors by a telomeric repeat amplification protocol (TRAP). Methods Cell Sci., 17: 1-15, 1995.
17. Wright, W. E., Shay, J. W., and Piatyszek, M. A. Modifications of a telomeric repeat amplification protocol (TRAP) result in increased reliability, linearity and sensitivity. Nucleic Acids Res., 23: 3794-3795, 1995.
18. Ohyashiki, J. H., Ohyashiki, K., Toyama, K., and Shay, J. W. A non-radioactive fluorescence-based telomeric repeat amplification protocol to detect and quantitate telomerase activity. Trends Genet., 12: 395-396, 1996.
19. Bennett, J. M., Catovsky, D., Daniel, M. T., Flandrin, G., Galton, D. A., Gralnick, H. R., and Sultan, C. Proposed revised criteria for the classification of acute myeloid leukemia: a report of the French-American-British Cooperative Group. Ann. Intern. Med., 103: 620-625, 1985.
20. Ohyashiki, K., Ohyashiki, J. H., Iwama, H., Hayashi, S., Shay, J. W., and Toyama, K. Telomerase reactivation in leukemia cells. Int. J. Oncol., 8: 417-421, 1996.
21. Ohyashiki, J. H., Ohyashiki, K., Fujimura, T., Kawakubo, K., Shimamoto, T., Iwabuchi, A., and Toyama, K. Telomere shortening associated with disease evolution patterns in myelodysplastic syndromes. Cancer Res., 54: 3557-3560, 1994.
22. Fujimura, T. Telomere shortening in hematopoietic neoplasias and its clinical implications. J. Tokyo Med. Coll., 55: 652-663, 1995.
23. Yamada, O., Oshimi, K., Motoji, T., and Mizoguchi, H. Telomeric DNA in normal and leukemic blood cells. J. Clin. Invest., 95: 1117-1123, 1995.
24. Kaplan, E. L., and Meier, P. Nonparametric estimation from incomplete observations. J. Am. Stat. Assoc., 53: 457-481, 1958.
25. Holt, S. E., Wright, W. E., and Shay, J. W. Regulation of telomerase activity in immortal cell lines. Mol. Cell. Biol., 16: 2932-2939, 1996.
26. Zhang, W., Piatyszek, M. A., Kobayashi, T., Estey, E., Andreeff, M., Deisserroth, A. B., Wright, W. E., and Shay, J. W. Telomerase activity in human acute myelogenous leukemia: inhibition of telomerase activity by differentiation-inducing agents. Clin. Cancer Res., 2: 799-803, 1996.
27. Shay, J. W., Werbin, H., and Wright, W. E. Telomeres and telomerase in human leukemias. Leukemia (Baltimore), 10:1255-1261, 1996.
28. Hiyama, E., Hiyama, K., Yokoyama, T., Matsuura, Y., Piatyszek, M. A., and Shay, J. W. Correlating telomerase activity levels with human neuroblastoma outcomes. Nat. Med., 1: 249-255, 1995.
29. Hiyama, E., Yokoyama, T., Tatsumoto, N., Hiyama, K., Imamura, Y., Murakami, Y., Kodama, T., Piatyszek, M. A., Shay, J. W., and Matsuura, Y. Telomerase activity in gastric cancer. Cancer Res., 55: 3258-3262, 1996.
30. Grignani, F., Fagioli, M., Alcalay, M., Longo, L., Pandolfi, P. P., Donti, E., Biondi, A., Lo Coco, F., Grignani, F., and Pelicci, P. G. Acute promyelocytic leukemia: from genetics to treatment. Blood, 83: 10-25, 1994.